Marketing-authorisation holder · United States
Am Regent
15 medicines in 1 country, as authorisation holder.
Loading your page…
Marketing-authorisation holder · United States
15 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
15 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CALCIUM CHLORIDE 10%100mg/ml · Injectable | Calcium chloride | United States | Marketed | 2017 |
| CHLOROTHIAZIDE SODIUM500mg base/vial · Injectable | Chlorothiazide | United States | Marketed | 2009 |
| DEXFERRUM50mg iron/ml · Injectable | Iron dextran | United States | Not marketed | 1996 |
| DEXTROSE 5%50mg/ml · Injectable | Dextrose | United States | Not marketed | 2024 |
| FOMEPIZOLE1.5gm/1.5ml (1gm/ml) · Injectable | Fomepizole | United States | Marketed | 2007 |
| INJECTAFER100mg iron/2ml (50mg iron/ml) | 1gm iron/20ml (50mg iron/ml) | 500mg iron/10ml (50mg iron/ml) | 750mg iron/15ml (50mg iron/ml) · Solution | Ferric carboxymaltose | United States | Marketed | 2013 |
| ISOSULFAN BLUE10mg/ml (10mg/ml) | 30mg/3ml (10mg/ml) | 50mg/5ml (10mg/ml) · Solution | Isosulfan blue | United States | Marketed | 2010 |
| LEUCOVORIN CALCIUM PRESERVATIVE FREE100mg base/vial | 200mg base/vial | 350mg base/vial | 500mg base/vial | 50mg base/vial · Injectable | Calcium folinate | United States | Marketed | 1995 |
| LEVOCARNITINE200mg/ml · Injectable | Levocarnitine | United States | Marketed | 2001 |
| MULTRYS60mcg copper/ml; 3mcg base/ml; 6mcg selenium/ml; 1000mcg base/ml (1ml) · Solution | Cupric, Manganese, Selenious acid, Zinc | United States | Marketed | 2020 |
| ONDANSETRON4mg/2ml · Injectable | Ondansetron | United States | Marketed | 2008 |
| TRALEMENT0.3mg copper/ml; 55mcg base/ml; 60mcg selenium/ml; 3mg base/ml (1ml) | 0.3mg copper/ml; 55mcg base/ml; 60mcg selenium/ml; 3mg base/ml (5ml) · Solution | Cupric, Manganese, Selenious acid, Zinc | United States | Marketed | 2020 |
| TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE100mg/ml · Injectable | Trimethobenzamide | United States | Not marketed | 2011 |
| VENOFER100mg iron/5ml (eq 20mg iron/ml) | 200mg iron/10ml (eq 20mg iron/ml) | 50mg iron/2.5ml (eq 20mg iron/ml) | 65mg iron/3.25ml (eq 20mg iron/ml) | 75mg iron/3.75ml (eq 20mg iron/ml) · Injectable | Iron sucrose | United States | Marketed | 2000 |
| ZIDOVUDINE10mg/ml · Injectable | Zidovudine | United States | Not marketed | 2010 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 15 | 15 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.